A review of the clinical experience with CMN-001, a tumor RNA loaded dendritic cell immunotherapy for the treatment of metastatic renal cell carcinoma.

Autor: DeBenedette M; Department of Research & Development, CoImmune Inc., Durham, NC, USA., Gamble A; Department of Research & Development, CoImmune Inc., Durham, NC, USA., Norris M; Department of Research & Development, CoImmune Inc., Durham, NC, USA., Horvatinovich J; Department of Research & Development, CoImmune Inc., Durham, NC, USA., Nicolette CA; Department of Research & Development, CoImmune Inc., Durham, NC, USA.

Publikováno v: Human vaccines & immunotherapeutics [Hum Vaccin Immunother] 2023 Aug 01; Vol. 19 (2), pp. 2220629. Date of Electronic Publication: 2023 Jun 30.

Results of the ADAPT Phase 3 Study of Rocapuldencel-T in Combination with Sunitinib as First-Line Therapy in Patients with Metastatic Renal Cell Carcinoma.

Autor: Figlin RA; Cedars-Sinai Medical Center Los Angeles, California., Tannir NM; University of Texas, MD Anderson Cancer Center Houston, Texas., Uzzo RG; Fox Chase Cancer Center, Temple University Health System, Philadelphia, Pennsylvania., Tykodi SS; Fred Hutchinson Cancer Research Center, University of Washington, Seattle, Washington., Chen DYT; Fox Chase Cancer Center, Temple University Health System, Philadelphia, Pennsylvania., Master V; Emory University Department of Urology, Emory University Hospital, Atlanta, Georgia., Kapoor A; Urologic Cancer Centre for Research and Innovation, Hamilton, Ontario, Canada., Vaena D; Holden Comprehensive Cancer Center, University of Iowa, Iowa City, Iowa., Lowrance W; Huntsman Cancer Hospital, University of Utah, Salt Lake City, Utah., Bratslavsky G; SUNY Upstate Medical University, Syracuse, New York., DeBenedette M; Argos Therapeutics Inc., now CoImmune Inc., Durham, North Carolina. mdebenedette@coimmune.com., Gamble A; Argos Therapeutics Inc., now CoImmune Inc., Durham, North Carolina., Plachco A; Argos Therapeutics Inc., now CoImmune Inc., Durham, North Carolina., Norris MS; Argos Therapeutics Inc., now CoImmune Inc., Durham, North Carolina., Horvatinovich J; Argos Therapeutics Inc., now CoImmune Inc., Durham, North Carolina., Tcherepanova IY; Argos Therapeutics Inc., now CoImmune Inc., Durham, North Carolina., Nicolette CA; Argos Therapeutics Inc., now CoImmune Inc., Durham, North Carolina., Wood CG

Publikováno v: Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2020 May 15; Vol. 26 (10), pp. 2327-2336. Date of Electronic Publication: 2020 Feb 07.

1137O - Interim analysis of the phase 3 ADAPT trial evaluating rocapuldencel-T (AGS-003), an individualized immunotherapy for the treatment of newly-diagnosed patients with metastatic renal cell carcinoma (mRCC)

Autor: Figlin, R., Nicolette, C., Tannir, N., Tykodi, S.S., Chen, D., Master, V., Lane, B., Debenedette, M., Monesmith, T., Tan, W., Leland, S., Wood, C.G.

Publikováno v: In Annals of Oncology September 2017 28 Supplement 5:v404-v404

Dendritic Cell Immunotherapy for HIV-1 Infection Using Autologous HIV-1 RNA: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial.

Autor: Jacobson JM; Division of Infectious Diseases and HIV Medicine, Drexel University College of Medicine, Philadelphia, PA; †Division of Hematology and Chronic Viral Illness Service, McGill University, Montreal, Quebec, Canada; ‡Department of Epidemiology and Biostatistics, Drexel University College of Medicine, Philadelphia, PA; §Argostherapeutics, Durham, NC; ‖Division of Infectious Diseases, The Ottawa Hospital and the University of Ottawa, Ottawa, CA; ¶Department of Internal Medicine, University of California Davis Medical Center, Sacramento, CA; #Department of Medicine, Albert Einstein College of Medicine, New York, NY; **Clinique Medicale du Quartier Latin, Montreal, Quebec, Canada; ††Duke University Medical Center, Durham, NC; ‡‡UNC HIV Cure Center and Departments of Medicine, Microbiology & Immunology, University of North Carolina at Chapel Hill, Chapel Hill, NC; §§Clinique Medicale l'Actuel, Montreal, Quebec, Canada; and ‖‖Frontier Science, Amherst, NY., Routy JP, Welles S, DeBenedette M, Tcherepanova I, Angel JB, Asmuth DM, Stein DK, Baril JG, McKellar M, Margolis DM, Trottier B, Wood K, Nicolette C

Publikováno v: Journal of acquired immune deficiency syndromes (1999) [J Acquir Immune Defic Syndr] 2016 May 01; Vol. 72 (1), pp. 31-8.

48 A novel method to improve antigen presentation and immunopotency of RNA-loaded monocyte-derived dendritic cells

Autor: Tcherepanova, I., Raney, A., Martin, B., Norris, M., Monesmith, T., DeBenedette, M., Healey, D., Miesowicz, F., Nicolette, C.

Publikováno v: In EJC Supplements 2010 8(7):24-24